InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Smith Jason Drew. Officer active across 1 companies, notably UroGen Pharma Ltd.. Aggregated, 6 reports have been recorded. Total volume traded: €65k. The latest transaction was filed on 17 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
833 shares
Ordinary Shares
SEC:0001209191-22-006387·
833 shares
Ordinary Shares
SEC:0001209191-22-006387:0·
8,333 shares
Ordinary Shares
SEC:0001209191-21-067440·
8,333 shares
Ordinary Shares
SEC:0001209191-21-067440:0·
€32,3072,500 shares@ €12.92270.0023% mcap100.0% of flow
Common Stock
SEC:0001209191-21-033399·
Ideal exit: 11 Feb 2022 (T+270)
€32,3072,500 shares@ €12.92270.0023% mcap50.0% of flow
Common Stock
SEC:0001209191-21-033399:0·
Ideal exit: 11 Feb 2022 (T+270)
6 of 6 declarations
About Smith Jason Drew
Jason Drew Smith is a director at UroGen Pharma Ltd.
